Concepedia

Monika Lamparska‐Przybysz

ML

Statistics

Publications

9

Citations

460

H-Index

9

Active since

2002

Affiliations

Celon Pharma (Poland)(Current)

University of Warsaw

Medical University of Lodz

Medical University of Warsaw

Warsaw University of Life Sciences

Monika Lamparska‐Przybysz is an author at Celon Pharma (Poland) specializing in cell death, breast cancer, and autophagy.

ORCID

Top concepts

Publications per year

2002–2014

9

Publications

9

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer

Lubomir Bodnar, Aleksandra Stańczak, Szczepan Cierniak et al. · Journal of Ovarian Research · 2014 · 80 citations · Full text

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma

Aleksandra Stańczak, Lubomir Bodnar, Wojciech Olszewski et al. · Pathology & Oncology Research · 2011 · 77 citations · Full text

Cathepsins and BID are involved in the molecular switch between apoptosis and autophagy in breast cancer MCF-7 cells exposed to camptothecin.

Monika Lamparska‐Przybysz, B Gajkowska, T. Motyl · PubMed · 2005 · 71 citations

, , +19

Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells

Paulina Grygielewicz, Barbara Dymek, Anna Bujak et al. · Gastric Cancer · 2014 · 69 citations · Full text

Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy.

T. Motyl, B Gajkowska, Joanna Zarzyńska et al. · PubMed · 2006 · 50 citations

, , +23

1–5 of 9